Furong Cheng

1.3k total citations
34 papers, 1.0k citations indexed

About

Furong Cheng is a scholar working on Biomaterials, Biomedical Engineering and Immunology. According to data from OpenAlex, Furong Cheng has authored 34 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Biomaterials, 10 papers in Biomedical Engineering and 8 papers in Immunology. Recurrent topics in Furong Cheng's work include Nanoplatforms for cancer theranostics (10 papers), Nanoparticle-Based Drug Delivery (9 papers) and RNA Interference and Gene Delivery (5 papers). Furong Cheng is often cited by papers focused on Nanoplatforms for cancer theranostics (10 papers), Nanoparticle-Based Drug Delivery (9 papers) and RNA Interference and Gene Delivery (5 papers). Furong Cheng collaborates with scholars based in China, United States and Japan. Furong Cheng's co-authors include Shun Yu, Giorgio Vivacqua, Bin He, Ting Su, Jun Cao, Yuji Pu, Guizhi Zhu, Yaohua Li, Kenji Uéda and Guangwei Liu and has published in prestigious journals such as Accounts of Chemical Research, Chemical Engineering Journal and ACS Applied Materials & Interfaces.

In The Last Decade

Furong Cheng

33 papers receiving 1.0k citations

Peers

Furong Cheng
Hyejin Park United States
Siva P. Kambhampati United States
Qi Shen China
Furong Cheng
Citations per year, relative to Furong Cheng Furong Cheng (= 1×) peers Chen-Meng Qiao

Countries citing papers authored by Furong Cheng

Since Specialization
Citations

This map shows the geographic impact of Furong Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Furong Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Furong Cheng more than expected).

Fields of papers citing papers by Furong Cheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Furong Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Furong Cheng. The network helps show where Furong Cheng may publish in the future.

Co-authorship network of co-authors of Furong Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Furong Cheng. A scholar is included among the top collaborators of Furong Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Furong Cheng. Furong Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Shurong, Yuqing Liang, Yu Hao, et al.. (2025). Combined cancer immunotherapy with lipid nanoparticle delivery of oligo-based cGAS-agonistic adjuvant and peptide or mRNA vaccines. Molecular Therapy — Nucleic Acids. 36(3). 102623–102623. 2 indexed citations
2.
Chen, Yuying, Furong Cheng, Yulin Liu, et al.. (2024). Integrative single-cell transcriptomic analyses reveal the cellular ontological and functional heterogeneities of primary and metastatic liver tumors. Journal of Translational Medicine. 22(1). 206–206. 9 indexed citations
3.
Zhou, Shurong, Ting Su, Furong Cheng, et al.. (2024). Engineering cGAS-agonistic oligonucleotides as therapeutics for cancer immunotherapy. Molecular Therapy — Nucleic Acids. 35(1). 102126–102126. 8 indexed citations
4.
Cheng, Furong, Ting Su, Shurong Zhou, et al.. (2023). Targeting Lymph Nodes for Systemic Immunosuppression Using Cell‐Free‐DNA‐Scavenging And cGAS‐Inhibiting Nanomedicine‐In‐Hydrogel for Rheumatoid Arthritis Immunotherapy. Advanced Science. 10(26). e2302575–e2302575. 38 indexed citations
5.
Cheng, Furong. (2023). Advantages of Combined Chinese and Western Medicine in Treating Liver Cancer. 4(2). 1 indexed citations
6.
Su, Ting, Shurong Zhou, Fuwu Zhang, et al.. (2023). Lymph node-targeting adjuvant/neoantigen-codelivering vaccines for combination glioblastoma radioimmunotherapy. Theranostics. 13(13). 4304–4315. 2 indexed citations
7.
Su, Ting, Xiang Liu, Shuibin Lin, Furong Cheng, & Guizhi Zhu. (2023). Ionizable polymeric nanocarriers for the codelivery of bi-adjuvant and neoantigens in combination tumor immunotherapy. Bioactive Materials. 26. 169–180. 26 indexed citations
8.
Zhou, Shurong, et al.. (2023). Engineering and Delivery of cGAS-STING Immunomodulators for the Immunotherapy of Cancer and Autoimmune Diseases. Accounts of Chemical Research. 56(21). 2933–2943. 48 indexed citations
9.
Su, Ting, Furong Cheng, Yuji Pu, et al.. (2021). Polymeric micelles amplify tumor oxidative stresses through combining PDT and glutathione depletion for synergistic cancer chemotherapy. Chemical Engineering Journal. 411. 128561–128561. 47 indexed citations
10.
Hai, Zhang, Jianqin Yan, Heng Mei, et al.. (2020). High-drug-loading capacity of redox-activated biodegradable nanoplatform for active targeted delivery of chemotherapeutic drugs. Regenerative Biomaterials. 7(4). 359–369. 10 indexed citations
11.
Cheng, Furong, Ting Su, Kui Luo, Yuji Pu, & Bin He. (2019). The polymerization kinetics, oxidation-responsiveness, and in vitro anticancer efficacy of poly(ester-thioether)s. Journal of Materials Chemistry B. 7(6). 1005–1016. 23 indexed citations
12.
Huang, Shuxuan, Furong Cheng, Zhong Pei, et al.. (2018). Berberine Protects Secondary Injury in Mice with Traumatic Brain Injury Through Anti-oxidative and Anti-inflammatory Modulation. Neurochemical Research. 43(9). 1814–1825. 33 indexed citations
13.
Yan, Jianqin, Hai Zhang, Furong Cheng, et al.. (2018). Highly stable RGD/disulfide bridge-bearing star-shaped biodegradable nanocarriers for enhancing drug-loading efficiency, rapid cellular uptake, and on-demand cargo release. International Journal of Nanomedicine. Volume 13. 8247–8268. 13 indexed citations
14.
Cai, Mengtan, Jun Cao, Zhengzhong Wu, et al.. (2017). In vitro and in vivo anti-tumor efficiency comparison of phosphorylcholine micelles with PEG micelles. Colloids and Surfaces B Biointerfaces. 157. 268–279. 34 indexed citations
15.
Yan, Jianqin, Ting Su, Furong Cheng, et al.. (2017). Multifunctional nanoparticles self-assembled from polyethylenimine-based graft polymers as efficient anticancer drug delivery. Colloids and Surfaces B Biointerfaces. 155. 118–127. 19 indexed citations
16.
Cheng, Furong, Huấn Cao, Ting Su, et al.. (2015). Characteristic of core materials in polymeric micelles effect on their micellar properties studied by experimental and dpd simulation methods. International Journal of Pharmaceutics. 492(1-2). 152–160. 29 indexed citations
17.
Cao, Jun, Furong Cheng, Huấn Cao, et al.. (2014). Framework effect of amphiphilic polyesters on their molecular movement and protein adsorption-resistance properties. Colloids and Surfaces B Biointerfaces. 125. 213–221. 7 indexed citations
18.
Cheng, Furong, Xin Li, Yaohua Li, et al.. (2011). α‐Synuclein promotes clathrin‐mediated NMDA receptor endocytosis and attenuates NMDA‐induced dopaminergic cell death. Journal of Neurochemistry. 119(4). 815–825. 62 indexed citations
19.
Han, Junyan, Chen Zhang, Qiu‐Lan Ma, et al.. (2011). C-terminal part of α-synuclein mediates its activity in promoting proliferation of dopaminergic cells. Journal of Neural Transmission. 118(8). 1155–1164. 15 indexed citations
20.
Liu, Guangwei, Chunyan Zhang, Xin Li, et al.. (2009). α-Synuclein is differentially expressed in mitochondria from different rat brain regions and dose-dependently down-regulates complex I activity. Neuroscience Letters. 454(3). 187–192. 160 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026